Vasculitis & polymyalgia rheumatica

Clinical features, anti-neutrophil cytoplasmic antibody (ANCA) status, and human leucocyte antigen (HLA) phenotypes of patients diagnosed with both rheumatoid arthritis and granulomatosis with polyangiitis: a case series of six patients with predominant myeloperoxidase (MPO)-ANCA positivity and HLA-DR4/DQ8/DPB1*04:01 phenotype

Scand J RheumatolPublished Case series

Authors' conclusion

In this case series of patients diagnosed with both RA and GPA, a long latency period between the two diagnoses was observed in all cases. All patients were women, the majority had erosive arthritis, and many patients were affected by saddle nose deformity and/or subglottic stenosis. MPO-ANCA was present in the majority of patients, which has not been described before. All patients were HLA-DR4/DQ8/DPB1*04:01 positive.

Study context

Population
Patients diagnosed with both rheumatoid arthritis (RA) and granulomatosis with polyangiitis (GPA), followed at the authors' department for AAVall women
Participants
6 patients
Outcome
Clinical features, ANCA status and HLA phenotypes
Methodological detailssingle-centre, Genomic HLA typing by routine methods
  • Single-centre
  • Genomic HLA typing by routine methods

Main finding

As reported in the abstract

Women
6
MPO-ANCA positive
5
PR3-ANCA positive
1
Erosive joint disease
5
IgM-RF and/or anti-CCP positive
6
Localized GPA
5
Systemic GPA
1
Subglottic stenosis
4
Saddle nose deformity
3
Median time between the two diagnoses, years (range 7-17)
13
RA before GPA
4
GPA before RA
2

Observational data: associations, not effects.

Original publication

Clinical features, anti-neutrophil cytoplasmic antibody (ANCA) status, and human leucocyte antigen (HLA) phenotypes of patients diagnosed with both rheumatoid arthritis and granulomatosis with polyangiitis: a case series of six patients with predominant myeloperoxidase (MPO)-ANCA positivity and HLA-DR4/DQ8/DPB1*04:01 phenotype. Scand J Rheumatol. Published 9 June 2026. doi:10.1080/03009742.2026.2666986

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.